TXT
53
-3
AVGO
18
-9
SLB
52
-3
FFIV
66
-4
ED
45
3
TDC
67
-4
AMGN
42
-4
MCD
52
-5
GS
72
4
PEG
62
4
KO
38
-3
UNH
57
-2
APH
65
-3
T
48
3
VRSK
68
-12
WHR
65
-5
CL
54
3
ZBH
65
3
HSIC
45
5
XEL
67
2
TXT
53
-3
AVGO
18
-9
SLB
52
-3
FFIV
66
-4
ED
45
3
TDC
67
-4
AMGN
42
-4
MCD
52
-5
GS
72
4
PEG
62
4
KO
38
-3
UNH
57
-2
APH
65
-3
T
48
3
VRSK
68
-12
WHR
65
-5
CL
54
3
ZBH
65
3
HSIC
45
5
XEL
67
2
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
37

VRNA
Verona Pharma PLC

Last Price:
35.65
Seasonality Move:
20.55%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Verona Pharma PLC Price Quote

$35.65
-0.01 (0.79%)
(Updated: November 16, 2024 at 5:44 AM ET)

Verona Pharma PLC Key Stats

Sell
37
Verona Pharma PLC (VRNA) is a Sell
Day range:
$34.71 - $35.97
52-week range:
$11.39 - $40.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
22.18%
Volume:
985.4K
Avg. volume:
1M
1-year change:
148.5%
Market cap:
$2.9B
Revenue:
$0
EPS:
$-2

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

  • How Much Debt Does Verona Pharma PLC Have?
    Total long term debt quarterly is $120M
  • How Much Cash Does Verona Pharma PLC Have?
    Cash and short term investments quarterly total is $336M
  • What Is Verona Pharma PLC’s Book Value Per Share?
    Book value per share is 1.59

Is Verona Pharma PLC Cash Flow Positive?

  • What Is VRNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$103.8M
  • What Is Verona Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $180.6M
  • What Is Verona Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$45K

Verona Pharma PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    VRNA return on invested capital is -55.17%
  • What Is Verona Pharma PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -45.04%
  • What Is VRNA Return On Equity?
    ROE is a measure of profitability and is -74.15%

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • NuCana PLC (NCNA)
    • TC BioPharm (Holdings) PLC (TCBP)

Verona Pharma PLC Dividend Yield

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -36.59%
Revenue: 0% 180.53%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 46.57
Upside from Last Price: 30.6%

Major Shareholders

  • How many VRNA shares are owned by institutional investors?
    89.1M VRNA shares are owned by institutional investors
  • How many VRNA shares are owned by insiders?
    42.2M VRNA shares are owned by insiders